Health Affairs, 23, no. 1 (2004): 7-8 doi: 10.1377/hlthaff.23.1.7 © 2004 by Project HOPE	New Online   Senate Health Reform Bill   Rewarding Providers   Public Option Policy Brief   Health Reform & Abortion   Delivery System Reform

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Iglehart, J. K. Search for Related Content PubMed Articles by Iglehart, J. K.

From The Editor

An Industry Under Siege Mounts Counterattack

The pharmaceutical industry faces a greater set of challenges today than ever before in its very successful history. Stakeholders from almost every conceivable corner are leveling criticism at the industry for the prices of its products, for its reliance on the United States to finance (through these higher prices) most of its research, and for its resistance to change ways that have long made it the most profitable sector in the U.S. economy. These and other complaints have become front-page news and prime-time television fare, but the industry is certainly not taking the criticism without strong rebuttals on multiple fronts. . . . [Full Text of this Article]

John K. Iglehart

Founding Editor

                      What's this?